Blood Culture Collection Strategies for Suspected Bloodstream Infection
SIMPLE-BC
Diagnostic Performance of Single-Venipuncture and Sequential Two-Venipuncture Blood Culture Collection Strategies in Adults With Suspected Bloodstream Infection: A Prospective Within-Participant Diagnostic Study
1 other identifier
interventional
3,000
1 country
1
Brief Summary
Blood cultures are the reference standard for diagnosing bloodstream infections and are essential for the management of patients with suspected sepsis. Their diagnostic performance depends strongly on the total volume of blood collected, while each additional venipuncture may increase patient discomfort, staff workload, and the opportunity for contamination. This prospective diagnostic study will evaluate two blood culture collection strategies within the same adult participant. Consecutive patients with a clinical indication for blood culture collection will be enrolled at Izola General Hospital. During the initial venipuncture, two complete blood culture sets, consisting of two aerobic and two anaerobic bottles and approximately 40 mL of blood, will be collected. One additional set, consisting of one aerobic and one anaerobic bottle and approximately 20 mL of blood, will then be collected from a second venipuncture site during the same diagnostic episode, generally within 30-60 minutes according to routine clinical workflow. The diagnostic performance of the single-venipuncture strategy will be determined from the initial four bottles. The diagnostic performance of the sequential two-venipuncture strategy will be determined from all six bottles. Each participant will therefore serve as their own control. The primary outcome is the paired difference in detection of clinically significant bloodstream pathogens. Secondary outcomes include the incremental diagnostic yield of the additional set, contamination, overall positivity, time to positivity, and the distribution of pathogens and contaminants. The investigators hypothesize that the single-venipuncture strategy will identify most clinically significant bloodstream pathogens detected by the complete protocol, while the additional set will provide a measurable but limited incremental diagnostic yield.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 3, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
August 7, 2026
August 1, 2026
5 months
August 3, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Paired difference in detection of clinically significant bloodstream pathogens
For each participant, detection of at least one clinically significant bloodstream pathogen using the initial four bottles collected during one venipuncture will be compared with detection using all six bottles collected during the complete sequential protocol. Results will be reported as paired proportions and the absolute paired difference with a 95% confidence interval.
From initial collection through completion of the five-day blood culture incubation period
Secondary Outcomes (3)
Incremental diagnostic yield of the additional blood culture set
From initial collection through completion of the five-day blood culture incubation period
Blood culture contamination
From initial collection through completion of the five-day blood culture incubation period
Overall blood culture positivity
From initial collection through completion of the five-day blood culture incubation period
Study Arms (1)
Standardized Six-Bottle Blood Culture Collection
EXPERIMENTALAll participants undergo an initial single venipuncture yielding four blood culture bottles, followed by an additional two-bottle set collected from a second venipuncture site during the same diagnostic episode, generally within 30-60 minutes. Diagnostic results from the initial four bottles are compared with results from all six bottles within the same participant.
Interventions
Two aerobic and two anaerobic blood culture bottles, targeting approximately 40 mL of blood, are collected during the initial venipuncture. One additional aerobic and one anaerobic bottle, targeting approximately 20 mL, are collected from a different venipuncture site during the same diagnostic episode, generally within 30-60 minutes. The complete collection totals six bottles and approximately 60 mL of blood.
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Clinical indication for blood culture collection determined by the treating physician as part of routine care.
- Planned collection of peripheral blood cultures during the current diagnostic episode.
- Ability to complete the study collection protocol.
- Informed consent obtained in accordance with the ethics committee approval and institutional requirements.
You may not qualify if:
- Inability to obtain blood cultures from two separate peripheral venipuncture sites.
- A clinical condition in which the treating physician considers the additional blood collection inappropriate or unsafe.
- Inability to obtain the intended blood volume because of failed collection or premature discontinuation.
- Blood cultures collected exclusively through an intravascular catheter.
- Declined consent or withdrawal of permission for study participation or use of study data, where applicable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Izola General Hospitallead
- University of Primorskacollaborator
Study Sites (1)
Izola General Hospital
Izola, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mladen Gasparini
Izola General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Samo Jeverica, MD, PhD
Study Record Dates
First Submitted
August 3, 2026
First Posted
August 7, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
August 7, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share